3,855
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Vaccination herd effect experience in Latin America: a systematic literature review

ORCID Icon, , , ORCID Icon, , , & show all
Pages 49-71 | Received 24 May 2018, Accepted 11 Aug 2018, Published online: 19 Sep 2018

References

  • de Quadros C. Historical perspectives on new vaccine introduction in Latin America and the Caribbean. Vaccine. 2013;31(Suppl 3):C4–C5.
  • Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis. 1998;4:561–570. doi:10.3201/eid0404.980406.
  • Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161. doi:10.1016/S0140-6736(12)60560-1.
  • Center for Disease Control and Prevention. Increased transmission and outbreaks of measles — European region, 2011. Morbidity Mortality Weekly Rep. 2011;60:1605–1641.
  • WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the weekly epidemiological record. Wkly Epidemiol Rec. 2006;81:445–452.
  • Danovaro-Holliday MC, Garcia S, de Quadros C, Tambini G, Andrus JK. Progress in vaccination against Haemophilus influenzae type b in the Americas. PLoS Med. 2008;5:e87. doi:10.1371/journal.pmed.0050087.
  • Peltola H. Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J. 16;1997:780–787.
  • Vergison A, Hanquet G. Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance. Pediatr Infect Dis J. 2012;31:400–403. doi:10.1097/INF.0b013e31824bc1f0.
  • O’Brien KL, Wolfson LJ, Watt JP, Henkle E, oria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi:10.1016/S0140-6736(09)61204-6.
  • Scott JA. The preventable burden of pneumococcal disease in the developing world. Vaccine. 2007;25:2398–2405. doi:10.1016/j.vaccine.2006.09.008.
  • Pneumococcal conjugate vaccine for childhood immunization–WHO position paper. Wkly Epidemiol Rec. World Health Organization. 2007;82:93–104.
  • Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43:683–689. doi:10.3109/00365548.2011.582247.
  • Smith PG. Concepts of herd protection and immunity. Procedia Vaccinol. 2010;2:134–139. doi:10.1016/j.provac.2010.07.005.
  • Scarbrough Lefebvre CD, Terlinden A, Standaert B. Dissecting the indirect effects caused by vaccines into the basic elements. Hum Vaccin Immunother. 2015;11:2142–2157. doi:10.1080/21645515.2015.1052196.
  • Anderson E, Shippee D, Weinrobe M, Davila M, Katz B, Lee S Cuyugan K, Noskin G. Decline in the prevalence of rotavirus in adults following widespread pediatric vaccination (Abstract LB-26). Infectious Diseases Society of America 49th Annual Meeting, Boston, USA, 20-23 October 2011.
  • Hanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine. 2013;31:5634–5642. doi:10.1016/j.vaccine.2013.07.006.
  • Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, Malfroot A, Swennen B, Sabbe M; Belgian IPD Scientific Committee. Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine. 2011;29:2856–2864. doi:10.1016/j.vaccine.2011.02.016.
  • Rodgers GL, Klugman KP. A new paradigm in pneumococcal conjugate vaccination: moving from individual to herd protection. Int J Infect Dis. 2017. doi:10.1016/j.ijid.2017.04.015.
  • De Oliveira LH, Giglio N, Ciapponi A, Garcia MS, Kuperman M, Sanwogou NJ, Ruiz-Matus C, Marinho de Sousa MF. Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine. 2013;31(Suppl 3):C99–108. doi:10.1016/j.vaccine.2013.05.065.
  • Andrade AL, Ternes YM, Vieira MA, Moreira WG, Lamaro-Cardoso J, Kipnis A, Cardoso MR, Brandileone MC, Moura I, Pimenta FC, et al. Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One. 2014;9:e98128. doi:10.1371/journal.pone.0098128.
  • Afonso ET, Minamisava R, Bierrenbach AL, Escalante JJ, Alencar AP, Domingues CM, Morais-Neto OL, Toscano CM, Andrade AL. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis. 2013;19:589–597. doi:10.3201/eid1904.121198.
  • Paternina-Caicedo A, Parashar UD, vis-Guzman N, De Oliveira LH, Castano-Zuluaga A, Cotes-Cantillo K, Gamboa-Garay O, Coronell-Rodríguez W, De la Hoz-Restrepo F. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine. 2015;33:3923–3928. doi:10.1016/j.vaccine.2015.06.058.
  • Thumburu KK, Singh M, Das RR, Jaiswal N, Agarwal A, Kumar A, Kaur H. Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trials. Ther Adv Vaccines. 2015;3:31–40. doi:10.1177/2051013615575871.
  • Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, Greenwood BM. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One. 2014;9:e103293. doi:10.1371/journal.pone.0103293.
  • Pollard SL, Malpica-Llanos T, Friberg IK, Fischer-Walker C, Ashraf S, Walker N. Estimating the herd immunity effect of rotavirus vaccine. Vaccine. 2015;33:3795–3800. doi:10.1016/j.vaccine.2015.06.064.
  • Dickinson Meneses FO, Pérez Rodríguez AE. Las meningoencefalitis bacterianas en la población infantil cubana: 1998-2000. Revista Cubana De Pediatría. 2002;72:106–114.
  • Kmetzsch CI, Schermann MT, Santana JC, Estima CL, Faraco FJ, Silva CM, Conceição R. [Occurrence of Haemophylus influenzae B meningitis after the implementation of a mass vaccination program]. J Pediatr (Rio J). 2003;79:530–536.
  • Miranzi SS, Moraes SA, Freitas IC. [Trends in Haemophilus influenzae type b meningitis in Brazil in children under five years of age from 1983 through 2002]. Rev Soc Bras Med Trop. 39;2006:473–477.
  • Montano A, Algorta G, Pírez C, Pascale A, Farcilli R, Ferrari AM. [Enfermedades invasivas por Haemophilus influenzae tipo b. Impacto de la vacunación en los niños que ingresan al Centro Hospitalario Pereira Rossell] Invasive diseases caused by Haemophilus influenzae type b. Impact of vaccination on infants at the Centro Hospitalario Pereira Rossell. Rev Méd Urug. 2001;17:166–170.
  • Ribeiro GS, Lima JB, Reis JN, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Ribeiro CT, Neves AB, Salgado K, et al. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine. 2007;25:4420–4428. doi:10.1016/j.vaccine.2007.03.024.
  • Andrade AL, Minamisava R, Policena G, Cristo EB, Domingues CM, de Cunto Brandileone MC, Almeida SC, Toscano CM, Bierrenbach AL. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis. Hum Vaccin Immunother. 2016;12:285–292. doi:10.1080/21645515.2015.1117713.
  • Becker-Dreps S, Amaya E, Liu L, Moreno G, Rocha J, Briceno R,Alemán J, Hudgens MG, Woods CW, Weber DJ. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J. 2014;33:637–642.
  • dos Santos Sr, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013;31:6150–6154. doi:10.1016/j.vaccine.2013.05.042.
  • Garcia Gabarrot G, Lopez Vega M, Perez Giffoni G, Hernandez S, Cardinal P, Felix V, Gabastou JM, Camou T; Uruguayan SIREVA II Group. Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One. 2014;9:e112337. doi:10.1371/journal.pone.0112337.
  • Gentile A, Bakir J, Bialorus L, Caruso L, Mirra D, Santander C, Terluk M, Zurdo P, Gentile F, Fernández MI. [Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: A population-based study]. Arch Argent Pediatr. 2015;113:502–509. doi:10.5546/aap.2015.502.
  • Hortal M, Estevan M, Meny M, Iraola I, Laurani H. Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. PLoS One. 2014;9:e98567. doi:10.1371/journal.pone.0098567.
  • Pirez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A, Giachetto G, Montano A. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J. 2014;33:753–759. doi:10.1097/INF.0000000000000294.
  • Valenzuela MT, Seoane M, Canals A, Pidal P, Hormazabal JC, Araya P, Terrazas S, Díaz J. [Laboratory surveillance of Streptococcus pneumoniae from invasive disease, Chile 2007-2012]. Rev Chilena Infectol. 2014;31:651–658. doi:10.4067/S0716-10182014000600002.
  • Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2012;16:e94–e98. doi:10.1016/j.ijid.2011.09.003.
  • do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8:e1001024. doi:10.1371/journal.pmed.1001024.
  • Esparza-Aguilar M, Gastanaduy PA, Sanchez-Uribe E, Desai R, Parashar UD, Richardson V, Patel M. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico. Bull World Health Organ. 2014;92:117–125. doi:10.2471/BLT.13.125286.
  • Gurgel RQ, Alvarez AJ, Rodrigues A, Ribeiro RR, Dolabella SS, Da Mota NL, Santos VS, Iturriza-Gomara M, Cunliffe NA, Cuevas LE. Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination. PLoS One. 2014;9:e110217. doi:10.1371/journal.pone.0110217.
  • Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011;15:e206–e210. doi:10.1016/j.ijid.2010.11.007.
  • Masukawa Mde L, Moriwaki AM, Uchimura NS, Souza EM, Uchimura TT. Intervention analysis of introduction of rotavirus vaccine on hospital admissions rates due to acute diarrhea. Cad Saude Publica. 30;2014:2101–2111.
  • Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM. Reduction of diarrhea-associated hospitalizations among children aged < 5 Years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J. 2011;30:S16–S20. doi:10.1097/INF.0b013e3181fefc68.
  • Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299–305. doi:10.1056/NEJMoa0905211.
  • Safadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil. Pediatr Infect Dis J. 2010;29:1019–1022. doi:10.1097/INF.0b013e3181e7886a.
  • Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J. 2011;30:S6–S10. doi:10.1097/INF.0b013e3181fefa05.
  • De Oliveira LH, Trumbo SP, Ruiz Matus C, Sanwogou NJ, Toscano CM. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned. Expert Rev Vaccines. 2016;15:1295–1304. doi:10.1586/14760584.2016.1166961.
  • Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33(Suppl 2):S161–S171. doi:10.1097/INF.0000000000000084.
  • Shiri T, Datta S, Madan J, Tsertsvadze A, Royle P, Keeling MJ, McCarthy ND, Petrou S. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e51–e59. doi:10.1016/S2214-109X(16)30306-0.
  • Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12:542–550.
  • Ruckinger S, van der LM, Reinert RR, von KR, Burckhardt F, Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine. 2009;27:4136–4141. doi:10.1016/j.vaccine.2009.04.057.
  • Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 19;2003:613–623.
  • Kim TH. Seasonal influenza and vaccine herd effect. Clin Exp Vaccine Res. 2014;3:128–132. doi:10.7774/cevr.2014.3.2.128.
  • Gomes MC, Gomes JJ, Paulo AC. Diphtheria, pertussis, and measles in Portugal before and after mass vaccination: A time series analysis. Eur J Epidemiol. 15;1999:791–798.